Kaski JC - Search Results

1

The effectiveness and cost-effectiveness of biomarkers for the prioritisation of patients awaiting coronary revascularisation: a systematic review and decision model.

Hemingway H, Henriksson M, Chen R, Damant J, Fitzpatrick N, Abrams K, Hingorani A, Janzon M, Shipley M, Feder G, Keogh B, Stenestrand U, McAllister K, Kaski JC, Timmis A, Palmer S, Sculpher M. Hemingway H, et al. Among authors: kaski jc. Health Technol Assess. 2010 Feb;14(9):1-151, iii-iv. doi: 10.3310/hta14090. Health Technol Assess. 2010. PMID: 20184812 Free article. Review.

2

Clinical trials update from the European Society of Cardiology Congress in Vienna, 2007: PROSPECT, EVEREST, ARISE, ALOFT, FINESSE, Prague-8, CARESS in MI and ACUITY.

Recio-Mayoral A, Kaski JC, McMurray JJ, Horowitz J, van Veldhuisen DJ, Remme WJ. Recio-Mayoral A, et al. Among authors: kaski jc. Cardiovasc Drugs Ther. 2007 Dec;21(6):459-65. doi: 10.1007/s10557-007-6069-4. Cardiovasc Drugs Ther. 2007. PMID: 17992567

3

Insulin resistance and endothelial dysfunction in the brothers of Indian subcontinent Asian women with polycystic ovaries.

Kaushal R, Parchure N, Bano G, Kaski JC, Nussey SS. Kaushal R, et al. Among authors: kaski jc. Clin Endocrinol (Oxf). 2004 Mar;60(3):322-8. doi: 10.1111/j.1365-2265.2004.01981.x. Clin Endocrinol (Oxf). 2004. PMID: 15008997

4

A rapid and reproducible on line automated technique to determine endothelial function.

Sidhu JS, Newey VR, Nassiri DK, Kaski JC. Sidhu JS, et al. Among authors: kaski jc. Heart. 2002 Sep;88(3):289-92. doi: 10.1136/heart.88.3.289. Heart. 2002. PMID: 12181226 Free PMC article.

5

[3H]bosentan binding to human coronary artery: functional correlates.

Dashwood MR, Timm M, Muddle JR, Shah D, Tippins JR, Kaski JC. Dashwood MR, et al. Among authors: kaski jc. J Cardiovasc Pharmacol. 1995;26 Suppl 3:S376-9. J Cardiovasc Pharmacol. 1995. PMID: 8587420

6

Endothelin-like immunoreactivity in atherosclerotic human coronary arteries.

Timm M, Kaski JC, Dashwood MR. Timm M, et al. Among authors: kaski jc. J Cardiovasc Pharmacol. 1995;26 Suppl 3:S442-4. J Cardiovasc Pharmacol. 1995. PMID: 8587440

7

HDL- cholesterol: a nut too hard to crack?

Kaski JC. Kaski JC. Cardiovasc Drugs Ther. 2012 Oct;26(5):433-4. doi: 10.1007/s10557-012-6401-5. Cardiovasc Drugs Ther. 2012. PMID: 22825352 No abstract available.

8

Regional variations in ETA/ETB binding sites in human coronary vasculature.

Dashwood MR, Timm M, Kaski JC. Dashwood MR, et al. Among authors: kaski jc. J Cardiovasc Pharmacol. 1995;26 Suppl 3:S351-4. J Cardiovasc Pharmacol. 1995. PMID: 8587412

9

Regional variations in endothelin-1 and its receptor subtypes in human coronary vasculature: pathophysiological implications in coronary disease.

Dashwood MR, Timm M, Muddle JR, Ong AC, Tippins JR, Parker R, McManus D, Murday AJ, Madden BP, Kaski JC. Dashwood MR, et al. Among authors: kaski jc. Endothelium. 1998;6(1):61-70. doi: 10.3109/10623329809053405. Endothelium. 1998. PMID: 9832333

10

Management of dyslipidaemia in patients with comorbidities - facing the challenge Value and limitations of lipid lowering drugs in liver disease Effects/Interactions of lipid-lowering agents on/with the liver.

Frühwald L, Fasching P, Dobrev D, Kaski JC, Borghi C, Wassmann S, Huber K, Semb AG, Agewall S, Drexel H. Frühwald L, et al. Among authors: kaski jc. Eur Heart J Cardiovasc Pharmacother. 2024 Dec 24:pvae095. doi: 10.1093/ehjcvp/pvae095. Online ahead of print. Eur Heart J Cardiovasc Pharmacother. 2024. PMID: 39719399

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

551 results

Search Page

Filters